Scarica l'app Stockscreener
16.25
1.46%
-0.24
Precedente Chiudi:
$16.49
Aprire:
$16.39
Volume 24 ore:
1.01M
Relative Volume:
2.11
Capitalizzazione di mercato:
$1.22B
Reddito:
$62.71M
Utile/perdita netta:
$-112.51M
Rapporto P/E:
-10.76
EPS:
-1.51
Flusso di cassa netto:
$-96.01M
1 W Prestazione:
+3.24%
1M Prestazione:
+15.25%
6M Prestazione:
+27.05%
1 anno Prestazione:
+24.52%
Intervallo 1D:
$16.05
$16.65
Intervallo di 1 settimana:
$15.49
$16.65
Portata 52W:
$9.03
$17.70
Zymeworks Inc. Stock (ZYME) Company Profile
Nome
Zymeworks Inc.
Settore
Industria
Telefono
604-678-1388
Indirizzo
1385 West 8th Avenue, Suite 540, Vancouver, BC
Confronta ZYME con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZYME
Zymeworks Inc.
|
16.25 | 1.25B | 62.71M | -112.51M | -96.01M | -1.51 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Zymeworks Inc. Stock (ZYME) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-20 | Iniziato | TD Cowen | Buy |
| 2024-12-16 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-11-07 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-11-01 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-03-21 | Ripresa | Wells Fargo | Overweight |
| 2023-01-04 | Reiterato | H.C. Wainwright | Neutral |
| 2022-12-20 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-11-01 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-10-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-10-04 | Ripresa | Wells Fargo | Overweight |
| 2022-05-05 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-03-15 | Iniziato | Evercore ISI | Outperform |
| 2021-12-10 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2021-11-17 | Ripresa | Guggenheim | Neutral |
| 2021-10-07 | Iniziato | Jefferies | Hold |
| 2021-03-31 | Iniziato | Credit Suisse | Outperform |
| 2021-02-25 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-02-08 | Ripresa | H.C. Wainwright | Buy |
| 2021-01-25 | Downgrade | Citigroup | Buy → Neutral |
| 2020-09-29 | Ripresa | JP Morgan | Neutral |
| 2020-08-06 | Iniziato | SVB Leerink | Outperform |
| 2020-01-10 | Iniziato | Wolfe Research | Outperform |
| 2019-12-09 | Iniziato | JP Morgan | Neutral |
| 2019-11-25 | Iniziato | H.C. Wainwright | Buy |
| 2019-11-20 | Iniziato | Guggenheim | Buy |
| 2019-09-30 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-08-30 | Iniziato | Stifel | Buy |
| 2019-07-18 | Iniziato | Deutsche Bank | Buy |
| 2018-05-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2018-03-19 | Iniziato | Raymond James | Outperform |
Mostra tutto
Zymeworks Inc. Borsa (ZYME) Ultime notizie
Zymeworks Inc. $ZYME Holdings Increased by UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC - MarketBeat
Rally Mode: What is the earnings history of Zymeworks Inc2025 Price Targets & AI Driven Price Predictions - khodrobank.com
Profit Recap: How does NLSPW compare to its peersPortfolio Growth Summary & Daily Entry Point Alerts - khodrobank.com
Buybacks Report: Can Zymeworks Inc withstand a market correction2025 Dividend Review & Free AI Powered Buy and Sell Recommendations - khodrobank.com
FOMO Trade: Can FMNB expand into new marketsWeekly Trend Report & Short-Term Trading Opportunity Alerts - خودرو بانک
Zymeworks to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025 - Orangeville.com
Aug Closing: Does Zymeworks Inc stock have upside surprise potentialTrade Ideas & Real-Time Buy Zone Alerts - khodrobank.com
Does Zymeworks Inc have strong EBITDA margins2025 Key Highlights & Daily Momentum Trading Reports - khodrobank.com
Macro Review: Will Zymeworks Inc. benefit from green energy policiesQuarterly Earnings Summary & AI Driven Stock Price Forecasts - khodrobank.com
Bull Run: Can Shuttle Pharmaceuticals Holdings Inc ride the EV waveProduct Launch & Low Drawdown Investment Ideas - خودرو بانک
Short Squeeze: Should you avoid Zymeworks Inc stock right nowJuly 2025 Reactions & Risk Controlled Stock Pick Alerts - khodrobank.com
Profit Recap: Will Zymeworks Inc benefit from geopolitical trendsWeekly Market Summary & Growth Oriented Trading Recommendations - khodrobank.com
Risk On: Does AGEN have pricing power2025 Risk Factors & High Return Trade Guides - خودرو بانک
Market reaction to Zymeworks Inc.’s recent newsWeekly Gains Summary & Free Technical Pattern Based Buy Signals - newser.com
Will Zymeworks Inc. rebound enough to break evenLayoff News & Growth Focused Stock Reports - newser.com
Statistical indicators supporting Zymeworks Inc.’s strengthTrade Performance Summary & Verified Swing Trading Watchlists - newser.com
Volatility clustering patterns for Zymeworks Inc.Portfolio Value Summary & Safe Capital Growth Stock Tips - newser.com
Can Zymeworks Inc. rally from current levelsMarket Volume Summary & Entry and Exit Point Strategies - newser.com
Real time alert setup for Zymeworks Inc. performanceMarket Trend Report & Stock Portfolio Risk Control - newser.com
Is Zymeworks Inc. stock entering bullish territoryTrade Exit Report & Technical Entry and Exit Alerts - newser.com
How Investors May Respond To Zymeworks (ZYME) Ending ZW171 Trials and Focusing on Zanidatamab - simplywall.st
Zymeworks (ZYME): Evaluating Valuation After Global Approvals for Zanidatamab and Pipeline Progress - Sahm
Bloom Burton Weighs in on Zymeworks FY2025 Earnings - MarketBeat
Zymeworks Inc.'s (NASDAQ:ZYME) 25% Price Boost Is Out Of Tune With Revenues - 富途牛牛
EcoR1 Capital LLC Has $205.56 Million Stock Holdings in Zymeworks Inc. $ZYME - MarketBeat
Trexquant Investment LP Acquires 118,813 Shares of Zymeworks Inc. $ZYME - MarketBeat
Is Zymeworks Inc. likely to announce a buybackEarnings Risk Report & Low Risk High Win Rate Stock Picks - Lancaster City Council
Analysts Set Zymeworks Inc. (NYSE:ZYME) Price Target at $21.43 - MarketBeat
Zymeworks Inc. Chart Enters High Volatility Zone2025 Technical Overview & Community Trade Idea Sharing - beatles.ru
Zymeworks (NASDAQ:ZYME) Shares Gap DownHere's What Happened - MarketBeat
Will Zymeworks Inc. benefit from geopolitical trends2025 Pullback Review & Safe Entry Trade Signal Reports - beatles.ru
Vestal Point Capital LP Has $5.96 Million Stock Holdings in Zymeworks Inc. $ZYME - MarketBeat
Can Zymeworks Inc. be recession proof2025 Bull vs Bear & Verified Trade Idea Suggestions - beatles.ru
ADAR1 Capital Management LLC Purchases New Holdings in Zymeworks Inc. $ZYME - MarketBeat
Zymeworks Inc. $ZYME Shares Sold by Redmile Group LLC - MarketBeat
Can Zymeworks Inc. maintain its current growth rate2025 Momentum Check & Risk Adjusted Buy/Sell Alerts - classian.co.kr
Optimistic Investors Push Zymeworks Inc. (NASDAQ:ZYME) Shares Up 25% But Growth Is Lacking - simplywall.st
Is Zymeworks Inc. affected by consumer sentimentJuly 2025 Closing Moves & Detailed Earnings Play Strategies - 강소기업뉴스
Zymeworks (NYSE:ZYME) Shares Gap DownShould You Sell? - MarketBeat
Has Zymeworks Inc. found a price floorWeekly Gains Report & Capital Efficient Trade Techniques - Newser
What Fibonacci levels say about Zymeworks Inc. reboundTrade Analysis Report & Fast Gain Stock Trading Tips - Newser
Real time breakdown of Zymeworks Inc. stock performanceWeekly Market Report & Long Hold Capital Preservation Tips - Newser
Zymeworks Inc. $ZYME Shares Sold by Wellington Management Group LLP - MarketBeat
What candlestick patterns are forming on Zymeworks Inc.New Guidance & Expert Approved Momentum Trade Ideas - Newser
Risk adjusted return profile for Zymeworks Inc. analyzedWeekly Trading Summary & Long-Term Investment Growth Plans - Newser
Heatmap analysis for Zymeworks Inc. and competitorsWeekly Trade Analysis & Free Risk Controlled Daily Trade Plans - Newser
What’s the fair value of Zymeworks Inc. stock2025 Valuation Update & Real-Time Market Trend Scan - خودرو بانک
Zymeworks Inc. Azioni (ZYME) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.43%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):